Showing results (681-690 of 3,965) with videos related to

Sort By:
Pageof 397
Translational Cancer Research|February 12, 2026
PHGDH knockdown activates autophagic flux to suppress migration and invasion of gastric cancer cellsShaowei Li, Yue Cao, Wenzhuo Xu, et al.
Translational Cancer Research|February 12, 2026
A case report of hemophagocytic lymphohistiocytosis secondary to tislelizumab and bevacizumab combination therapy for renal cell carcinomaLinli Shi, Xiaobing Li, Rong Xie, et al.
Translational Cancer Research|February 12, 2026
IL20RB as a prognostic and immune-related biomarker in lung cancer: association with immune infiltration, tumor progression, and potential therapeutic targetingHefei Li, Jiajia Tan, Hongjun Chu, et al.
Translational Cancer Research|February 12, 2026
Key genes and pathway differences between serrated polyps and conventional adenomas: insights from multi-omicsYoutao Zhou, Cuiyan Yang, Yuan Gao, et al.
Translational Cancer Research|February 12, 2026
Establishment and validation of a prognostic model based on liquid-liquid phase separation-related genes in gastric cancerYueli Tian, Ruifeng Duan, Jianwen Li, et al.
Translational Cancer Research|January 9, 2026
Impact of underlying liver etiology on post-hepatectomy survival outcomes in hepatocellular carcinoma patientsAtsushi Nanashima, Junichi Arai, Naoya Imamura, et al.
Translational Cancer Research|January 9, 2026
Prognostic implications of a programmed cell death-related long non-coding RNA signature and its relevance to immune features in esophageal carcinomaWentao Xiao, Xinying Fang, Shubin Luo, et al.
Translational Cancer Research|January 9, 2026
The role of microRNAs in gastritis, intestinal metaplasia, and gastric cancer: a narrative reviewZi Gao, Kaiyue Fu, Peijuan Li, et al.
Translational Cancer Research|January 9, 2026
Identification of differentiation markers and immune microenvironment in head and neck squamous cell carcinoma using machine learning combined with single-cell analysisZishanbai Zhang, Yue Li, Miao Wang, et al.
Translational Cancer Research|January 9, 2026
Successful treatment of lung squamous cell carcinoma with envafolimab, a PD-L1 inhibitor combined with chemotherapy: a case reportXin Sun, Yu Tang, Yue Zhu, et al.
Pageof 397